Cardiovascular disease in systemic sclerosis

Annals of Translational Medicine

Volumn 3, Issue 1, 2015, Pages

  Cannarile, Francesca ^a   Valentini, Valentina ^a   Mirabelli, Giulia ^a   Alunno, Alessia ^a   Terenzi, Riccardo ^a   Luccioli, Filippo ^a   Gerli, Roberto ^a   Bartoloni, Elena ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Atherosclerosis (ATS); Cardiovascular (CV) disease; Systemic sclerosis (SSc)

Indexed keywords

EID: 85015470494     PISSN: 23055839     EISSN: 23055847     Source Type: Journal    
DOI: 10.3978/j.issn.2305-5839.2014.12.12     Document Type: Review

References (97)

1. Dumoitier N, Lofek S, Mouthon L. Pathophysiology of systemic sclerosis: state of the art in 2014. Presse Med 2014;43:e267-78.
2. Papagoras C, Achenbach K, Tsifetaki N, et al. Heart involvement in systemic sclerosis: a combined echocardiographic and scintigraphic study. Clin Rheumatol 2014;33:1105-11.
3. Rubio-Rivas M, Royo C, Simeón CP, et al. Mortality and survival in systemic sclerosis: Systematic review and meta-analysis. Semin Arthritis Rheum 2014;44:208-19.
4. Bartoloni Bocci E, Luccioli F, Angrisani C, et al. Accelerated atherosclerosis in systemic lupus erythematosus and other connective tissue diseases. Expert Rev Clin Immunol 2007;3:531-41.
5. Shoenfeld Y, Gerli R, Doria A, et al. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 2005;112:3337-47.
6. Bartoloni E, Alunno A, Bistoni O, et al. How early is the atherosclerotic risk in rheumatoid arthritis? Autoimmun Rev 2010;9:701-7.
7. Sarzi-Puttini P, Atzeni F, Gerli R, et al. Cardiac involvement in systemic rheumatic diseases: An update. Autoimmun Rev 2010;9:849-52.
8. Bartoloni E, Shoenfeld Y, Gerli R. Inflammatory and autoimmune mechanisms in the induction of atherosclerotic damage in systemic rheumatic diseases: two faces of the same coin. Arthritis Care Res (Hoboken) 2011;63:178-83.
9. Hettema ME, Bootsma H, Kallenberg CG. Macrovascular disease and atherosclerosis in SSc. Rheumatology (Oxford) 2008;47:578-83.
10. Au K, Singh MK, Bodukam V, et al. Atherosclerosis in systemic sclerosis: a systematic review and meta-analysis. Arthritis Rheum 2011;63:2078-90.
11. Soriano A, Afeltra A, Shoenfeld Y. Is atherosclerosis accelerated in systemic sclerosis? Novel insights. Curr Opin Rheumatol 2014;26:653-7.
12. Blagojevic J, Matucci Cerinic M. Macrovascular involvement in systemic sclerosis: comorbidity or accelerated atherosclerosis? Curr Rheumatol Rep 2007;9:181-2.
13. Tyndall AJ, Bannert B, Vonk M, et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 2010;69:1809-15.
14. Dave AJ, Fiorentino D, Lingala B, et al. Atherosclerotic cardiovascular disease in hospitalized patients with systemic sclerosis: higher mortality than patients with lupus and rheumatoid arthritis. Arthritis Care Res (Hoboken) 2014;66:323-7.
15. Ngian GS, Sahhar J, Wicks IP, et al. Cardiovascular disease in systemic sclerosis-an emerging association? Arthritis Res Ther 2011;13:237.
16. Nussinovitch U, Shoenfeld Y. Atherosclerosis and macrovascular involvement in systemic sclerosis: myth or reality. Autoimmun Rev 2011;10:259-66.
17. Matucci-Cerinic M, Kahaleh B, Wigley FM. Review: evidence that systemic sclerosis is a vascular disease. Arthritis Rheum 2013;65:1953-62.
18. Ngian GS, Sahhar J, Proudman SM, et al. Prevalence of coronary heart disease and cardiovascular risk factors in a national cross-sectional cohort study of systemic sclerosis. Ann Rheum Dis 2012;71:1980-3.
19. Zeng Y, Li M, Xu D, et al. Macrovascular involvement in systemic sclerosis: evidence of correlation with disease activity. Clin Exp Rheumatol 2012;30:S76-80.
20. Man A, Zhu Y, Zhang Y, et al. The risk of cardiovascular disease in systemic sclerosis: a population-based cohort study. Ann Rheum Dis 2013;72:1188-93.
21. Mok MY, Lau CS, Chiu SS, et al. Systemic sclerosis is an independent risk factor for increased coronary artery calcium deposition. Arthritis Rheum 2011;63:1387-95.
22. Zakopoulos NA, Kotsis VT, Gialafos EJ, et al. Systemic sclerosis is not associated with clinical or ambulatory blood pressure. Clin Exp Rheumatol 2003;21:199-204.
23. Lippi G, Caramaschi P, Montagnana M, et al. Lipoprotein[a] and the lipid profile in patients with systemic sclerosis. Clin Chim Acta 2006;364:345-8.
24. Borba EF, Borges CT, Bonfá E. Lipoprotein profile in limited systemic sclerosis. Rheumatol Int 2005;25:379-83.
25. Szucs G, Tímár O, Szekanecz Z, et al. Endothelial dysfunction precedes atherosclerosis in systemic sclerosis-relevance for prevention of vascular complications. Rheumatology (Oxford) 2007;46:759-62.
26. Altorok N, Wang Y, Kahaleh B. Endothelial dysfunction in systemic sclerosis. Curr Opin Rheumatol 2014;26:615-20.
27. Fleming JN, Nash RA, Mahoney WM Jr, et al. Is scleroderma a vasculopathy? Curr Rheumatol Rep 2009;11:103-10.
28. Farouk HM, Hamza SH, El Bakry SA, et al. Dysregulation of angiogenic homeostasis in systemic sclerosis. Int J Rheum Dis 2013;16:448-54.
29. Maurer B, Distler A, Suliman YA, et al. Vascular endothelial growth factor aggravates fibrosis and vasculopathy in experimental models of systemic sclerosis. Ann Rheum Dis 2014;73:1880-7.
30. Bartoloni E, Alunno A, Bistoni O, et al. Characterization of circulating endothelial microparticles and endothelial progenitor cells in primary Sjögren's syndrome: new markers of chronic endothelial damage? Rheumatology (Oxford) 2014. [Epub ahead of print].
31. Del Papa N, Quirici N, Soligo D, et al. Bone marrow endothelial progenitors are defective in systemic sclerosis. Arthritis Rheum 2006;54:2605-15.
32. Kuwana M, Okazaki Y, Yasuoka H, et al. Defective vasculogenesis in systemic sclerosis. Lancet 2004;364:603-10.
33. Avouac J, Juin F, WipffJ, et al. Circulating endothelial progenitor cells in systemic sclerosis: association with disease severity. Ann Rheum Dis 2008;67:1455-60.
34. Allanore Y, Batteux F, Avouac J, et al. Levels of circulating endothelial progenitor cells in systemic sclerosis. Clin Exp Rheumatol 2007;25:60-6.
35. Kuwana M, Okazaki Y. Brief report: impaired in vivo neovascularization capacity of endothelial progenitor cells in patients with systemic sclerosis. Arthritis Rheumatol 2014;66:1300-5.
36. Del Papa N, Quirici N, Scavullo C, et al. Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis. J Rheumatol 2010;37:2053-63.
37. Erdbruegger U, Haubitz M, Woywodt A. Circulating endothelial cells: a novel marker of endothelial damage. Clin Chim Acta 2006;373:17-26.
38. Del Papa N, Colombo G, Fracchiolla N, et al. Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis. Arthritis Rheum 2004;50:1296-304.
39. Dimitroulas T, Giannakoulas G, Karvounis H, et al. Micro-and macrovascular treatment targets in scleroderma heart disease. Curr Pharm Des 2014;20:536-44.
40. Rosato E, Gigante A, Barbano B, et al. In systemic sclerosis macrovascular damage of hands digital arteries correlates with microvascular damage. Microvasc Res 2011;82:410-5.
41. Youssef P, Brama T, Englert H, et al. Limited scleroderma is associated with increased prevalence of macrovascular disease. J Rheumatol 1995;22:469-72.
42. Veale DJ, Collidge TA, Belch JJ. Increased prevalence of symptomatic macrovascular disease in systemic sclerosis. Ann Rheum Dis 1995;54:853-5.
43. Ho M, Veale D, Eastmond C, et al. Macrovascular disease and systemic sclerosis. Ann Rheum Dis 2000;59:39-43.
44. Wan MC, Moore T, Hollis S, et al. Ankle brachial pressure index in systemic sclerosis: influence of disease subtype and anticentromere antibody. Rheumatology (Oxford) 2001;40:1102-5.
45. Wig S, Wilkinson J, Moore T, et al. A longitudinal study of ankle brachial pressure indices in a cohort of patients with systemic sclerosis. Rheumatology (Oxford) 2014;53:2009-13.
46. Bartoli F, Angotti C, Fatini C, et al. Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosis. Rheumatology (Oxford) 2007;46:772-5.
47. Kaloudi O, Basta G, Perfetto F, et al. Circulating levels of Nepsilon-(carboxymethyl)lysine are increased in systemic sclerosis. Rheumatology (Oxford) 2007;46:412-6.
48. Domsic RT, Dezfulian C, Shoushtari A, et al. Endothelial dysfunction is present only in the microvasculature and microcirculation of early diffuse systemic sclerosis patients. Clin Exp Rheumatol 2014;32:S154-S160.
49. Colaci M, Giuggioli D, Manfredi A, et al. Aortic pulse wave velocity measurement in systemic sclerosis patients. Reumatismo 2012;64:360-7.
50. Timár O, Soltész P, Szamosi S, et al. Increased arterial stiffness as the marker of vascular involvement in systemic sclerosis. J Rheumatol 2008;35:1329-33.
51. Gosse P, Taillard J, Constans J, et al. Evolution of ambulatory measurement of blood pressure and parameters of arterial stiffness over a 1-year period in patients with systemic sclerosis: ERAMS study. J Hum Hypertens 2002;16:627-30.
52. Dick EA, Aviv R, Francis I, et al. Catheter angiography and angioplasty in patients with scleroderma. Br J Radiol 2001;74:1091-6.
53. Emad Y, Al-Sherbeni H, Ragab Y, et al. Arterial vasculopathy in systemic sclerosis: Computerized tomography (CT) angiographic features of macrovascular and microvascular upper limbs arteries. Joint Bone Spine 2014;81:433-7.
54. Lekakis J, Mavrikakis M, Papamichael C, et al. Short-term estrogen administration improves abnormal endothelial function in women with systemic sclerosis and Raynaud's phenomenon. Am Heart J 1998;136:905-12.
55. Bartoli F, Blagojevic J, Bacci M, et al. Flow-mediated vasodilation and carotid intima-media thickness in systemic sclerosis. Ann N Y Acad Sci 2007;1108:283-90.
56. Rollando D, Bezante GP, Sulli A, et al. Brachial artery endothelial-dependent flow-mediated dilation identifies early-stage endothelial dysfunction in systemic sclerosis and correlates with nailfold microvascular impairment. J Rheumatol 2010;37:1168-73.
57. Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010;55:1318-27.
58. Ngian GS, Sahhar J, Wicks IP, et al. Arterial stiffness is increased in systemic sclerosis: a cross-sectional comparison with matched controls. Clin Exp Rheumatol 2014;32:S161-S166.
59. Mahmud A, Feely J. Arterial stiffness is related to systemic inflammation in essential hypertension. Hypertension 2005;46:1118-22.
60. Cypiene A, Laucevicius A, Venalis A, et al. The impact of systemic sclerosis on arterial wall stiffness parameters and endothelial function. Clin Rheumatol 2008;27:1517-22.
61. Turiel M, Gianturco L, Ricci C, et al. Silent cardiovascular involvement in patients with diffuse systemic sclerosis: a controlled cross-sectional study. Arthritis Care Res (Hoboken) 2013;65:274-80.
62. Piccione MC, Bagnato G, Zito C, et al. Early identification of vascular damage in patients with systemic sclerosis. Angiology 2011;62:338-43.
63. Liu J, Zhang Y, Cao TS, et al. Preferential macrovasculopathy in systemic sclerosis detected by regional pulse wave velocity from wave intensity analysis: comparisons of local and regional arterial stiffness parameters in cases and controls. Arthritis Care Res (Hoboken) 2011;63:579-87.
64. Sfikakis PP, Papamichael C, Stamatelopoulos KS, et al. Improvement of vascular endothelial function using the oral endothelin receptor antagonist bosentan in patients with systemic sclerosis. Arthritis Rheum 2007;56:1985-93.
65. Peled N, Shitrit D, Fox BD, et al. Peripheral arterial stiffness and endothelial dysfunction in idiopathic and scleroderma associated pulmonary arterial hypertension. J Rheumatol 2009;36:970-5.
66. Roustit M, Simmons GH, Baguet JP, et al. Discrepancy between simultaneous digital skin microvascular and brachial artery macrovascular post-occlusive hyperemia in systemic sclerosis. J Rheumatol 2008;35:1576-83.
67. Chiang CH, Liu CJ, Huang CC, et al. Systemic sclerosis and risk of ischaemic stroke: a nationwide cohort study. Rheumatology (Oxford) 2013;52:161-5.
68. Lee JE, Haynes JM. Carotid arteritis and cerebral infarction due to scleroderma. Neurology 1967;17:18-22.
69. Schedel J, Kuchenbuch S, Schoelmerich J, et al. Cerebral lesions in patients with connective tissue diseases and systemic vasculitides: are there specific patterns? Ann N Y Acad Sci 2010;1193:167-75.
70. Terrier B, Charbonneau F, Touzé E, et al. Cerebral vasculopathy is associated with severe vascular manifestations in systemic sclerosis. J Rheumatol 2009;36:1486-94.
71. Bertinotti L, Mortilla M, Conforti ML, et al. Proton magnetic resonance spectroscopy reveals central neuroaxonal impairment in systemic sclerosis. J Rheumatol 2006;33:546-51.
72. Pathak R, Gabor AJ. Scleroderma and central nervous system vasculitis. Stroke 1991;22:410-3.
73. Hietarinta M, Lassila O, Hietaharju A. Association of anti-U1RNP-and anti-Scl-70-antibodies with neurological manifestations in systemic sclerosis (scleroderma). Scand J Rheumatol 1994;23:64-7.
74. Chen XY, Lam WW, Ng HK, et al. Intracranial artery calcification: a newly identified risk factor of ischemic stroke. J Neuroimaging 2007;17:300-3.
75. Heron E, Hernigou A, Chatellier G, et al. Intracerebral calcification in systemic sclerosis. Stroke 1999;30:2183-5.
76. Tanabe J. White matter hyperintensities are associated with an increased risk of stroke, dementia and mortality. Evid Based Ment Health 2011;14:1.
77. Sardanelli F, Iozzelli A, Cotticelli B, et al. White matter hyperintensities on brain magnetic resonance in systemic sclerosis. Ann Rheum Dis 2005;64:777-9.
78. Mohamed RH, Nassef AA. Brain magnetic resonance imaging findings in patients with systemic sclerosis. Int J Rheum Dis 2010;13:61-7.
79. Nobili F, Cutolo M, Sulli A, et al. Brain functional involvement by perfusion SPECT in systemic sclerosis and Behçet's disease. Ann N Y Acad Sci 2002;966:409-14.
80. Roquer J, Segura T, Serena J, et al. Endothelial dysfunction, vascular disease and stroke: the ARTICO study. Cerebrovasc Dis 2009;27:25-37.
81. Faucher B, Granel B, Nicoli F. Acute cerebral vasculopathy in systemic sclerosis. Rheumatol Int 2013;33:3073-7.
82. Héron E, Fornes P, Rance A, et al. Brain involvement in scleroderma: two autopsy cases. Stroke 1998;29:719-21.
83. Hettema ME, Zhang D, de Leeuw K, et al. Early atherosclerosis in systemic sclerosis and its relation to disease or traditional risk factors. Arthritis Res Ther 2008;10:R49.
84. Sherer Y, Cerinic MM, Bartoli F, et al. Early atherosclerosis and autoantibodies to heat-shock proteins and oxidized LDL in systemic sclerosis. Ann N Y Acad Sci 2007;1108:259-67.
85. Tyrrell PN, Beyene J, Feldman BM, et al. Rheumatic disease and carotid intima-media thickness: a systematic review and meta-analysis. Arterioscler Thromb Vasc Biol 2010;30:1014-26.
86. Lorenz MW, Markus HS, Bots ML, et al. Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007;115:459-67.
87. Vettori S, Maresca L, Cuomo G, et al. Clinical and subclinical atherosclerosis in systemic sclerosis: consequences of previous corticosteroid treatment. Scand J Rheumatol 2010;39:485-9.
88. Schiopu E, Au KM, McMahon MA, et al. Prevalence of subclinical atherosclerosis is increased in systemic sclerosis and is associated with serum proteins: a cross-sectional, controlled study of carotid ultrasound. Rheumatology (Oxford) 2014;53:704-13.
89. Ferri C, Giuggioli D, Sebastiani M, et al. Heart involvement and systemic sclerosis. Lupus 2005;14:702-7.
90. Chu SY, Chen YJ, Liu CJ, et al. Increased risk of acute myocardial infarction in systemic sclerosis: a nationwide population-based study. Am J Med 2013;126:982-8.
91. Nordin A, Jensen-Urstad K, Björnådal L, et al. Ischemic arterial events and atherosclerosis in patients with systemic sclerosis: a population-based case-control study. Arthritis Res Ther 2013;15:R87.
92. Derk CT, Jimenez SA. Acute myocardial infarction in systemic sclerosis patients: a case series. Clin Rheumatol 2007;26:965-8.
93. Akram MR, Handler CE, Williams M, et al. Angiographically proven coronary artery disease in scleroderma. Rheumatology (Oxford) 2006;45:1395-8.
94. Tarekel G, Yasser AE, Gheita T. Coronary angiographic findings in asymptomatic systemic sclerosis. Clin Rheumatol 2006;25:487-90.
95. Khurma V, Meyer C, Park GS, et al. A pilot study of subclinical coronary atherosclerosis in systemic sclerosis: coronary artery calcification in cases and controls. Arthritis Rheum 2008;59:591-7.
96. Mok MY, Chiu SS, Lo Y, et al. Coronary atherosclerosis using computed tomography coronary angiography in patients with systemic sclerosis. Scand J Rheumatol 2009;38:381-5.
97. Ungprasert P, Charoenpong P, Ratanasrimetha P, et al. Risk of coronary artery disease in patients with systemic sclerosis: a systematic review and meta-analysis. Clin Rheumatol 2014;33:1099-104.